July 09, 2026 a 04:39 pm
PODD: Analysts Ratings - Insulet Corp.
Insulet Corporation, a renowned leader in insulin delivery systems, has been a subject of increasing interest from analysts. The most recent data indicates a strong leaning towards 'Buy', suggesting optimism around its innovative product pipeline and strategic market positioning. However, some indicators point to a slight softening of enthusiasm, with a small uptick in 'Hold' recommendations, reflecting cautious optimism. Investors eyeing Insulet Corp. may find the current analyst sentiment indicative of balanced growth expectations with potential for upside surprises.
Historical Stock Grades
Based on the most recent data, the following trends have been observed in the analyst ratings for PODD as of July 1, 2026:
| Rating | Number | Score |
|---|---|---|
| Strong Buy | 4 | |
| Buy | 18 | |
| Hold | 3 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment development
Throughout the months, analyst sentiment towards Insulet Corp. has shown dynamic changes, emphasizing shifts in confidence and market conditions:
- The overall number of ratings has gradually decreased, which might signal a consolidation in analyst coverage or shifts in market interest.
- There has been a notable decrease in 'Strong Buy' recommendations, shifting towards more 'Buy' and 'Hold' positions, highlighting cautious optimism.
- Despite these shifts, there remains a clear absence of 'Sell' or 'Strong Sell' recommendations, supporting a generally positive long-term outlook.
Percentage trends
An analysis of the percentage distribution of ratings reveals subtle movements in sentiment:
- 'Strong Buy' percentages have decreased from earlier peaks, illustrating more measured bullish sentiment.
- 'Buy' recommendations remain dominant, representing over half of the total ratings, indicating strong confidence in the stock's performance.
- 'Hold' recommendations have seen a slight increase, suggesting greater caution or reevaluation of growth potential by some analysts.
- This shift towards 'Hold' can indicate market adjustments or perceived challenges, requiring careful monitoring by investors.
Over the last 12 months, Insulet Corp. has seen fluctuations in the analyst recommendations, with a key transition from predominantly 'Strong Buy' to a more balanced portfolio of 'Buy' and 'Hold'.
Latest Analyst Recommendations
Recent analyst updates have maintained stability without drastic changes in outlook:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-07-06 | Outperform | Outperform | Evercore ISI Group |
| 2026-06-12 | Buy | Buy | Truist Securities |
| 2026-05-28 | Neutral | Neutral | Citigroup |
| 2026-05-27 | Outperform | Outperform | RBC Capital |
| 2026-05-27 | Buy | Buy | BTIG |
Analyst Recommendations with Change of Opinion
Several analysts have adjusted their positions, indicating varied interpretations of Insulet Corp.'s market positioning:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-04-24 | Neutral | Buy | Rothschild & Co |
| 2026-04-07 | Neutral | Buy | Citigroup |
| 2026-01-12 | Underweight | Equal Weight | Barclays |
| 2025-11-19 | Buy | Neutral | UBS |
| 2025-05-13 | Outperform | Peer Perform | Wolfe Research |
Interpretation
Analyst sentiment suggests a broad consensus around Insulet Corp. as a viable investment, predominantly supported by 'Buy' ratings. The moderate increase in 'Hold' recommendations points to a nuanced view of market potential and strategy execution. A lack of 'Sell' ratings indicates underlying confidence from analysts. However, the observed downgrades in some recommendations could hint at emerging challenges or expectations of stabilization in growth. This balanced sentiment may signal a cautious yet optimistic stance among analysts regarding future performance.
Conclusion
Insulet Corp. stands as a leading entity in the diabetes management arena, with its stock enjoying robust support from analysts. While the recent sentiment trends illustrate a shift towards cautious optimism, the underlying analyst confidence remains resilient. Investors should watch for any significant changes in fundamental business conditions or industry dynamics that could influence this steady, positive outlook. Overall, analysts depict Insulet Corp. as a progressive company with strong potential, suggesting sustained, albeit cautiously optimistic, growth ahead.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years